Edition:
India

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.70USD
12 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.70
Open
$11.20
Day's High
$11.80
Day's Low
$11.20
Volume
42,267
Avg. Vol
31,821
52-wk High
$18.00
52-wk Low
$7.50

Chart for

About

Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of orphan diseases. Its pipeline includes Sarasar (lonafarnib) for hepatitis delta virus (HDV), exendin (9-39) for severe... (more)

Overall

Beta: 2.57
Market Cap(Mil.): $107.52
Shares Outstanding(Mil.): 8.37
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates